Areas of Focus
The science of optimism
Preventing the spread of infections
Combatting an evolving risk
Treatment at the molecular level
Smaller populations but big impact
China Research & Development Center
Pfizer China R&D Center (CRDC) is an important R&D hub of Pfizer in the world and the Asia Pacific region. It provides comprehensive support services for the development projects of the global product line. Over the past more than 30 years, Pfizer has introduced over 70 innovative products to China, including original drugs and vaccines. By 2025, Pfizer plans to achieve 24 breakthrough innovative products to apply for listing, and with the gradual implementation of the strategic goal of "80%&80%, we will try our best to realize the simultaneous application of product research and development in China to meet the health needs of Chinese patients at all stages of life.
Pfizer China R&D Center was established on October 31, 2005, at Shanghai Zhangjiang High-tech Park Zone. It is one of the earliest and largest R & D centers set up by multinational pharmaceutical enterprises in China.
In 2010, Pfizer China R&D center Wuhan Branch was established, located in Wuhan Biolake Science and Technology Industrial Park.